Cargando…
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare disorder of vascular development. Common manifestations include epistaxis, telangiectasias and arteriovenous malformations in multiple organs. Different deletions or nonsense mutations have been described in the ENG (HHT1) or ACVRL1/ALK1 (HHT2) g...
Autores principales: | Errasti Díaz, Suriel, Peñalva, Mercedes, Recio-Poveda, Lucía, Vilches, Susana, Casado-Vela, Juan, Pérez Pérez, Julián, Botella, Luisa María, Albiñana, Virginia, Cuesta, Angel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181680/ https://www.ncbi.nlm.nih.gov/pubmed/35683441 http://dx.doi.org/10.3390/jcm11113053 |
Ejemplares similares
-
Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)
por: Albiñana, Virginia, et al.
Publicado: (2019) -
Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021) -
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
por: Cuesta, Angel M., et al.
Publicado: (2022) -
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
por: Albiñana, Virginia, et al.
Publicado: (2022) -
Generation of a Syngeneic Heterozygous ACVRL1((wt/mut)) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis
por: Xiang-Tischhauser, Li, et al.
Publicado: (2023)